title: Atazanavir crystal nephropathy.
authors: Hassane
authors: H
authors: Izzedine
authors: Mona Ben
authors: MB
authors: M'rad
authors: Armelle
authors: A
authors: Bardier
authors: Michel
authors: M
authors: Daudon
authors: Dominique
authors: D
authors: Salmon
mesh_terms: D000069446:Atazanavir Sulfate; D002130:Calcium Phosphates; D003460:Crystallization; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000009:adverse effects*; D019698:Hepatitis C, Chronic / Q000150:complications / Q000188:drug therapy; D006801:Humans; D007669:Kidney Calculi / Q000139:chemically induced* / Q000821:virology; D008297:Male; D008875:Middle Aged; D009842:Oligopeptides / Q000009:adverse effects*; D011725:Pyridines / Q000009:adverse effects*
chemical_list: D002130:Calcium Phosphates; D017320:HIV Protease Inhibitors; D009842:Oligopeptides; D011725:Pyridines; D000069446:Atazanavir Sulfate; C020243:calcium phosphate